AU2003299901A8 - Thrombin inhibitors - Google Patents

Thrombin inhibitors

Info

Publication number: AU2003299901A8
Authority: AU; Australia
Prior art keywords: thrombin inhibitors; thrombin; inhibitors
Prior art date: 2002-10-04
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003299901A

Other versions

AU2003299901A1 (en

Inventor

Peter D Williams

Terry A Lyle

Philip E J Sanderson

Donnette D Staas

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Merck and Co Inc

Original Assignee

Merck and Co Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-04

Filing date

2003-09-30

Publication date

2004-05-04

2003-09-30 Application filed by Merck and Co Inc filed Critical Merck and Co Inc

2004-05-04 Publication of AU2003299901A8 publication Critical patent/AU2003299901A8/en

2004-05-04 Publication of AU2003299901A1 publication Critical patent/AU2003299901A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU2003299901A 2002-10-04 2003-09-30 Thrombin inhibitors Abandoned AU2003299901A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US41597602P	2002-10-04	2002-10-04
US60/415,976		2002-10-04
PCT/US2003/030867 WO2004032834A2 (en)	2002-10-04	2003-09-30	Thrombin inhibitors

Publications (2)

Publication Number	Publication Date
AU2003299901A8 true AU2003299901A8 (en)	2004-05-04
AU2003299901A1 AU2003299901A1 (en)	2004-05-04

Family

ID=32093790

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003299901A Abandoned AU2003299901A1 (en)	2002-10-04	2003-09-30	Thrombin inhibitors

Country Status (2)

Country	Link
AU (1)	AU2003299901A1 (en)
WO (1)	WO2004032834A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2006073167A1 (en) *	2005-01-07	2006-07-13	Ono Pharmaceutical Co., Ltd.	Pyrrolidine derivatives
EP1852419A4 (en) *	2005-01-27	2009-03-04	Mitsui Chemicals Inc	Method for producing fluorinated proline derivative
EP2386539B1 (en) *	2005-12-23	2016-07-20	Zealand Pharma A/S	4-Aminoproline derivatives useful as lysine mimetics
PE20091002A1 (en)	2007-06-13	2009-07-15	Bristol Myers Squibb Co	DIPEPTIDED ANALOGS AS INHIBITORS OF THE COAGULATION FACTOR
CA2727925A1 (en)	2008-06-23	2009-12-30	Astrazeneca Ab	New heterocyclic carboxamides for use as thrombin inhibitors
US20110275673A1 (en) *	2008-09-19	2011-11-10	Yibin Xiang	Inhibitors of sphingosine kinase 1
PE20151764A1 (en)	2013-02-22	2015-12-03	Pfizer	DERIVATIVES OF PIRROLO [2,3-D] PYRIMIDINE
ES2750655T3 (en)	2014-08-12	2020-03-26	Pfizer	Pyrrolo [2,3-d] pyrimidine derivatives useful to inhibit Janus kinase
CN104774160B (en) *	2015-03-09	2016-08-17	大连奇凯医药科技有限公司	A kind of preparation method of cyclopropyl fenpropathin derivative
CN112867706B (en) *	2018-05-29	2024-11-15	奥默罗斯公司	MASP-2 inhibitors and methods of use
CN115103709A (en)	2019-12-04	2022-09-23	奥默罗斯公司	MASP-2 inhibitors and methods of use
CN115052604A (en)	2019-12-04	2022-09-13	奥默罗斯公司	MASP-2 inhibitors and methods of use
AU2020395306B2 (en)	2019-12-04	2025-04-24	Omeros Corporation	MASP-2 inhibitors and methods of use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2005504003A (en) *	2001-02-09	2005-02-10	メルク　エンド　カムパニー　インコーポレーテッド	Thrombin inhibitor

2003
- 2003-09-30 WO PCT/US2003/030867 patent/WO2004032834A2/en not_active Ceased
- 2003-09-30 AU AU2003299901A patent/AU2003299901A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2004032834A3 (en)	2004-06-10
AU2003299901A1 (en)	2004-05-04
WO2004032834A2 (en)	2004-04-22

Publication	Publication Date	Title
DE60317493D1 (en)	2011-01-13	Trizyklische thrombin rezeptor antagonisten
EG25482A (en)	2012-01-15	Inhibitors
AU2003202263A1 (en)	2003-07-30	Roh-kinase inhibitors
AU2003300832A8 (en)	2004-06-30	Nf-kappab inhibitors
SI2594265T1 (en)	2016-03-31	Ca ix-specific inhibitors
EP1483254A4 (en)	2005-06-08	Resistance-repellent retroviral protease inhibitors
EP1532133A4 (en)	2006-11-15	Nf-:b inhibitors
GB0219961D0 (en)	2002-10-02	Oxytocin inhibitors
EP1663279A4 (en)	2009-02-18	Modified protease inhibitors
EP1704142A4 (en)	2008-08-20	Protease inhibitors
AU2003299901A8 (en)	2004-05-04	Thrombin inhibitors
IL164898A0 (en)	2005-12-18	Heterotricyclyl 6-alkylidene-penems as beta-lactamase inhibitors
AU2003269984A8 (en)	2004-03-11	Protease inhibitors
EP1531857A4 (en)	2008-10-08	Metalloproteinase inhibitors
AU2003224941A8 (en)	2003-10-27	Nf-kappab inhibitors
AU2003263738A8 (en)	2003-12-02	Protease inhibitors
AU2003304496A8 (en)	2005-04-27	Protease inhibitors
AU2003233642A8 (en)	2003-12-12	Protease inhibitors
AU2003269878A8 (en)	2003-12-22	Protease inhibitors
AU2003265240A8 (en)	2003-12-22	Protease inhibitors
GB0312619D0 (en)	2003-07-09	Complement inhibitors
IL165935A (en)	2010-12-30	Vasopeptidase inhibitors
GB0208094D0 (en)	2002-05-22	Inhibitors
GB0207488D0 (en)	2002-05-08	Inhibitors
GB0217330D0 (en)	2002-09-04	Inhibitors

Legal Events

Date	Code	Title	Description
2005-07-21	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase